- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03037333
Analysis in the EMERGEncy Between TransVenous Cardiac PACIng Guided by Fluoroscopy Versus Echocardiogram (EMERG-TV-PAC)
October 23, 2018 updated by: University of Sao Paulo General Hospital
Prospective Analysis in the EMERGEncy Between TransVenous Cardiac PACIng Guided by Fluoroscopy Versus Echocardiogram
A lot of questions about use of temporary transvenous pacing still remain obscure and there is no effective comparison between use of fluoroscopy versus electrocardiogram/echocardiogram in patients with bradicardias.
The aim of the study is to evaluate how long does it take to start the correct cardiac stimulation with transvenous pacing in patients with bradicardias comparing use of fluoroscopy versus electrocardiogram/echocardiogram and compare rates of complications between two methods.
Study Overview
Status
Unknown
Conditions
Detailed Description
Approximately 150 subjects will be recruited over a planned recruitment period of 18 months.
Patients will be submitted to ecchocardiogram using Philips Envisor, and electrocardiogram with Philips Healthcare PageWriter TC30.
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
São Paulo, SP, Brazil, 05.417-000
- Recruiting
- Instituto do Coração - HMFMUSP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- adult males and females aged > 18 years
- symptomatic bradicardia
- informed consent signed.
Exclusion Criteria:
- pregnancy
- hemodynamic instability (pulmonary congestion / systolic arterial pressure lower than 90 mmHg)
- body mass index greater than 40 kg/ m2
- use of oral anticoagulation
- acute coronary syndromes
- left ventricle ejection fraction < 45%
- presence of any kind of cardiac stimulation device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: fluoroscopy
|
Transvenous cardiac estimulation
|
|
Other: ECG/ECHO
|
Transvenous cardiac estimulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
all cause mortality
Time Frame: 1 week
|
1 week
|
|
|
infection
Time Frame: 1 week
|
Incidence of infection assessed by a clinical diagnosis
|
1 week
|
|
hematoma > 5 cm
Time Frame: 1 week
|
image
|
1 week
|
|
cardiac perforation
Time Frame: 1 week
|
Incidence of cardiac perforation assessed by a clinical diagnosis
|
1 week
|
|
pneumothorax
Time Frame: 1 week
|
Incidence of pneumothorax assessed by a clinical diagnosis
|
1 week
|
|
ventricular tachycardia
Time Frame: 1 week
|
Incidence of ventricular tachycardia assessed by an ECG test
|
1 week
|
|
loss of capture
Time Frame: 1 week
|
Incidence of loss of capture assessed by an ECG test
|
1 week
|
|
venous thrombosis
Time Frame: 1 week
|
Incidence of venous thrombosis assessed by an ultrasound
|
1 week
|
|
any complication the delays definitive pacemaker > 48 hours
Time Frame: 1 week
|
clinical diagnosis
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to start the correct cardiac stimulation with transvenous pacing
Time Frame: 1 week
|
minutes scale
|
1 week
|
|
rates of success
Time Frame: 1 week
|
ECG test
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Alexandre Soeiro, MD, Unidade Clínica de Emergência
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Esmaiel A, Hassan J, Blenkhorn F, Mardigyan V. The Use of Ultrasound to Improve Axillary Vein Access and Minimize Complications during Pacemaker Implantation. Pacing Clin Electrophysiol. 2016 May;39(5):478-82. doi: 10.1111/pace.12833. Epub 2016 Mar 23.
- Reusz G, Csomos A. The role of ultrasound guidance for vascular access. Curr Opin Anaesthesiol. 2015 Dec;28(6):710-6. doi: 10.1097/ACO.0000000000000245.
- Bouaziz H, Zetlaoui PJ, Pierre S, Desruennes E, Fritsch N, Jochum D, Lapostolle F, Pirotte T, Villiers S. Guidelines on the use of ultrasound guidance for vascular access. Anaesth Crit Care Pain Med. 2015 Feb;34(1):65-9. doi: 10.1016/j.accpm.2015.01.004. Epub 2015 Mar 5.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 16, 2017
Primary Completion (Anticipated)
December 1, 2018
Study Completion (Anticipated)
August 1, 2019
Study Registration Dates
First Submitted
January 18, 2017
First Submitted That Met QC Criteria
January 27, 2017
First Posted (Estimate)
January 31, 2017
Study Record Updates
Last Update Posted (Actual)
October 24, 2018
Last Update Submitted That Met QC Criteria
October 23, 2018
Last Verified
October 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PSInCor-EMERG-TV-PAC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bradycardia
-
University of Maryland, BaltimoreCompleted
-
Chang Gung Memorial HospitalBiotronik SE & Co. KGActive, not recruiting
-
University of Hamburg-EppendorfCompleted
-
University of ExeterRoyal Devon and Exeter NHS Foundation TrustCompletedSVT | Vagal BradycardiaUnited Kingdom
-
Augusta UniversityCompletedFetal BradycardiaUnited States
-
Medical University of GdanskCompletedBradycardia During Pulling of EyeballPoland
-
Abbott Medical DevicesCompletedStandard Bradycardia Pacing IndicationFrance, Germany, Italy, Japan
-
Medtronic Cardiac Ablation SolutionsCompleted
-
University of Sao Paulo General HospitalCompletedFetal Bradycardia | Hypertonic Uterine | CatecholaminesBrazil
-
South Western Ambulance Service NHS Foundation...Royal Devon and Exeter NHS Foundation Trust; Academic Health Science CentresCompletedEmergencies | SVT | Vagal BradycardiaUnited Kingdom
Clinical Trials on Transvenous cardiac pacing guided by fluoroscopy
-
Hunan Provincial People's HospitalRecruitingTachyarrhythmia | Brady-tachy Syndrome | Bradyarrhythmia | Bradycardia; Syncope | AVB - Atrioventricular Block | Tachycardia BradycardiaChina
-
Rush University Medical CenterCompletedHeart Failure, Systolic | Sinus Node Dysfunction | Heart Block AV | LBBBUnited States
-
M.D. Anderson Cancer CenterCompletedLung CarcinomaUnited States
-
Shanghai Youhe Medical Technology Co., Ltd.RecruitingLung Neoplasms | Pulmonary NeoplasmChina
-
Libin Cardiovascular Institute of AlbertaHeart and Stroke Foundation of CanadaCompletedImage Guidance | Cardiac Resynchronization Therapy | Systolic Heart Failure | Dysynchrony | Digital TwinsCanada
-
Uppsala University HospitalCompleted
-
University Hospital, Strasbourg, FranceUnknownVertebral Compression Fractures in Osteoporotic PatientsFrance
-
Cheng-Hsin General HospitalCompletedHeart Failure | HypotensionTaiwan